Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Pediatric Blood & Cancer
|
April 5, 2021
Pediatric classical Hodgkin lymphoma
Andrea C Lo, Karin Dieckmann, Tanja Pelz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2010
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study
Christine Mauz-Körholz, Dirk Hasenclever, Wolfgang Dörffel, et al.
Radiology
|
January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)
Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
JAMA Oncology
|
January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial
Stephen Daw, Alexander Claviez, Lars Kurch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?
Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
The Lancet. Oncology
|
March 1, 2023
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study
Christine Mauz-Körholz, Judith Landman-Parker, Ana Fernández-Teijeiro, et al.
Pediatric Blood & Cancer
|
February 4, 2021
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial
Lars Kurch, Christine Mauz-Körholz, Alexander Fosså, et al.
The Lancet. Oncology
|
December 13, 2021
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
Christine Mauz-Körholz, Judith Landman-Parker, Walentyna Balwierz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 10, 2025
Quantitative Deauville Scoring to Uncover Prognostic Information from <sup>18</sup>F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 Trial
Lars Kurch, Judith Landman-Parker, Thomas W Georgi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Pediatric Blood & Cancer
|
April 5, 2021
Pediatric classical Hodgkin lymphoma
Andrea C Lo, Karin Dieckmann, Tanja Pelz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2010
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study
Christine Mauz-Körholz, Dirk Hasenclever, Wolfgang Dörffel, et al.
Radiology
|
January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)
Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
JAMA Oncology
|
January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial
Stephen Daw, Alexander Claviez, Lars Kurch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2018
<sup>18</sup>F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?
Thomas W Georgi, Regine Kluge, Lars Kurch, et al.
The Lancet. Oncology
|
March 1, 2023
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study
Christine Mauz-Körholz, Judith Landman-Parker, Ana Fernández-Teijeiro, et al.
Pediatric Blood & Cancer
|
February 4, 2021
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial
Lars Kurch, Christine Mauz-Körholz, Alexander Fosså, et al.
The Lancet. Oncology
|
December 13, 2021
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
Christine Mauz-Körholz, Judith Landman-Parker, Walentyna Balwierz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 10, 2025
Quantitative Deauville Scoring to Uncover Prognostic Information from <sup>18</sup>F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 Trial
Lars Kurch, Judith Landman-Parker, Thomas W Georgi, et al.
Page
of 2